PFIZER INC Net Income (Loss) Available to Common Stockholders, Diluted
PFIZER INC (PFE) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$248.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-04
- PFIZER INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-28 was -$248.00M, a 108.52% decline year-over-year.
- PFIZER INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-29 was $2.69B, a 9.44% decline year-over-year.
- PFIZER INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was -$1.65B, a 501.95% decline year-over-year.
- PFIZER INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-28 was $3.54B, a 20.69% decline year-over-year.
- PFIZER INC net income (loss) available to common stockholders, diluted for fiscal 2025 was $7.77B, a 3.24% decline from fiscal 2024.
- PFIZER INC net income (loss) available to common stockholders, diluted for fiscal 2024 was $8.03B, a 279.00% increase from fiscal 2023.
- PFIZER INC net income (loss) available to common stockholders, diluted for fiscal 2023 was $2.12B, a 93.25% decline from fiscal 2022.
- PFIZER INC net income (loss) available to common stockholders, diluted for fiscal 2022 was $31.37B, a 42.74% increase from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | -$248.00M 10-Q · filed 2026-08-04 | $2.44B 10-Q · filed 2026-08-04 | $791.00M derived: sum of 3 quarters · filed 2026-08-04 | $4.33B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | $2.69B 10-Q · filed 2026-05-05 | $1.04B derived: sum of 2 quarters · filed 2026-05-05 | $4.58B derived: sum of 3 quarters · filed 2026-05-05 | $7.49B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$1.65B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.89B derived: sum of 2 quarters · filed 2026-02-26 | $4.80B derived: sum of 3 quarters · filed 2026-08-04 | $7.77B 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | $3.54B 10-Q · filed 2025-11-04 | $6.45B derived: sum of 2 quarters · filed 2026-08-04 | $9.42B 10-Q · filed 2025-11-04 | $9.83B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | $2.91B 10-Q · filed 2026-08-04 | $5.88B 10-Q · filed 2026-08-04 | $6.29B derived: sum of 3 quarters · filed 2026-08-04 | $10.75B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | $2.97B 10-Q · filed 2026-05-05 | $3.38B derived: sum of 2 quarters · filed 2026-05-05 | $7.84B derived: sum of 3 quarters · filed 2026-05-05 | $7.88B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $410.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.88B derived: sum of 2 quarters · filed 2026-02-26 | $4.92B derived: sum of 3 quarters · filed 2026-02-26 | $8.03B 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | $4.46B 10-Q · filed 2025-11-04 | $4.51B derived: sum of 2 quarters · filed 2025-11-04 | $7.62B 10-Q · filed 2025-11-04 | $4.25B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $41.00M 10-Q · filed 2025-08-05 | $3.16B 10-Q · filed 2025-08-05 | -$213.00M derived: sum of 3 quarters · filed 2026-02-26 | -$2.60B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $3.12B 10-Q · filed 2025-05-05 | -$254.00M derived: sum of 2 quarters · filed 2026-02-26 | -$2.64B derived: sum of 3 quarters · filed 2026-02-26 | -$309.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$3.37B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.75B derived: sum of 2 quarters · filed 2026-02-26 | -$3.42B derived: sum of 3 quarters · filed 2026-02-26 | $2.12B 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | -$2.38B 10-Q · filed 2024-11-04 | -$55.00M derived: sum of 2 quarters · filed 2024-11-04 | $5.49B 10-Q · filed 2024-11-04 | $10.48B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | $2.33B 10-Q · filed 2024-08-05 | $7.87B 10-Q · filed 2024-08-05 | $12.86B derived: sum of 3 quarters · filed 2025-02-27 | $21.47B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | $5.54B 10-Q · filed 2024-05-08 | $10.54B derived: sum of 2 quarters · filed 2025-02-27 | $19.14B derived: sum of 3 quarters · filed 2025-02-27 | $29.05B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $4.99B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $13.60B derived: sum of 2 quarters · filed 2025-02-27 | $23.51B derived: sum of 3 quarters · filed 2025-02-27 | $31.37B 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | $8.61B 10-Q · filed 2023-11-08 | $18.51B derived: sum of 2 quarters · filed 2023-11-08 | $26.38B 10-Q · filed 2023-11-08 | $29.77B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | $9.91B 10-Q · filed 2023-08-09 | $17.77B 10-Q · filed 2023-08-09 | $21.16B derived: sum of 3 quarters · filed 2024-02-22 | $29.31B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | $7.86B 10-Q · filed 2023-05-10 | $11.26B derived: sum of 2 quarters · filed 2024-02-22 | $19.40B derived: sum of 3 quarters · filed 2024-02-22 | $24.97B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $3.39B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $11.54B derived: sum of 2 quarters · filed 2024-02-22 | $17.10B derived: sum of 3 quarters · filed 2024-02-22 | $21.98B 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | $8.15B 10-Q · filed 2022-11-09 | $13.71B derived: sum of 2 quarters · filed 2022-11-09 | $18.59B 10-Q · filed 2022-11-09 | $19.43B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-07-04 | $5.56B 10-Q · filed 2022-08-10 | $10.44B 10-Q · filed 2022-08-10 | $11.29B derived: sum of 3 quarters · filed 2023-02-23 | $12.76B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-04-04 | $4.88B 10-Q · filed 2022-05-11 | $5.72B derived: sum of 2 quarters · filed 2023-02-23 | $7.19B derived: sum of 3 quarters · filed 2023-02-23 | $10.68B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $846.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.31B derived: sum of 2 quarters · filed 2023-02-23 | $5.80B derived: sum of 3 quarters · filed 2023-02-23 | $9.16B 10-K · filed 2023-02-23 | $9.62B 10-K · filed 2021-02-25 | |||
| 2020-09-27 | $1.47B 10-Q · filed 2021-11-12 | $2.19B 10-Q · filed 2020-11-05 | $4.96B derived: sum of 2 quarters · filed 2021-11-12 | $8.31B 10-Q · filed 2021-11-12 | $9.02B 10-Q · filed 2020-11-05 | $7.73B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $3.49B 10-Q · filed 2021-08-12 | $3.43B 10-Q · filed 2020-08-06 | $6.84B 10-Q · filed 2021-08-12 | $6.83B 10-Q · filed 2020-08-06 | $6.26B derived: sum of 3 quarters · filed 2022-02-24 | $13.94B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | $3.35B 10-Q · filed 2021-05-13 | $3.40B 10-Q · filed 2020-05-07 | $2.77B derived: sum of 2 quarters · filed 2022-02-24 | $10.45B derived: sum of 3 quarters · filed 2022-02-24 | $15.50B derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$583.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $7.10B derived: sum of 2 quarters · filed 2022-02-24 | $12.14B derived: sum of 3 quarters · filed 2022-02-24 | $16.03B 10-K · filed 2022-02-24 | $16.27B 10-K · filed 2020-02-27 | |||
| 2019-09-29 | $7.68B 10-Q · filed 2020-11-05 | $12.73B derived: sum of 2 quarters · filed 2020-11-05 | $16.61B 10-Q · filed 2020-11-05 | $16.22B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $5.05B 10-Q · filed 2020-08-06 | $8.93B 10-Q · filed 2020-08-06 | $8.54B derived: sum of 3 quarters · filed 2021-02-25 | $12.65B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $3.88B 10-Q · filed 2020-05-07 | $3.49B derived: sum of 2 quarters · filed 2021-02-25 | $7.61B derived: sum of 3 quarters · filed 2021-02-25 | $11.48B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$393.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.72B derived: sum of 2 quarters · filed 2021-02-25 | $7.59B derived: sum of 3 quarters · filed 2021-02-25 | $11.15B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $4.11B 10-Q · filed 2019-11-07 | $7.99B derived: sum of 2 quarters · filed 2019-11-07 | $11.55B 10-Q · filed 2019-11-07 | $23.82B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | $3.87B 10-Q · filed 2019-08-08 | $7.43B 10-Q · filed 2019-08-08 | $19.71B derived: sum of 3 quarters · filed 2020-02-27 | $22.55B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | $3.56B 10-Q · filed 2019-05-09 | $15.84B derived: sum of 2 quarters · filed 2020-02-27 | $18.68B derived: sum of 3 quarters · filed 2020-02-27 | $21.75B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $12.27B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $15.11B derived: sum of 2 quarters · filed 2020-02-27 | $18.19B derived: sum of 3 quarters · filed 2020-02-27 | $21.31B 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | $2.84B 10-Q · filed 2018-11-08 | $5.91B derived: sum of 2 quarters · filed 2018-11-08 | $9.03B 10-Q · filed 2018-11-08 | $9.81B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-07-02 | $3.07B 10-Q · filed 2018-08-09 | $6.19B 10-Q · filed 2018-08-09 | $6.97B derived: sum of 3 quarters · filed 2019-02-28 | $8.32B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-04-02 | $3.12B 10-Q · filed 2018-05-10 | $3.90B derived: sum of 2 quarters · filed 2019-02-28 | $5.25B derived: sum of 3 quarters · filed 2019-02-28 | $7.30B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $774.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $2.13B derived: sum of 2 quarters · filed 2019-02-28 | $4.18B derived: sum of 3 quarters · filed 2019-02-28 | $7.21B 10-K · filed 2019-02-28 | ||||
| 2016-10-02 | $1.35B 10-Q · filed 2017-11-09 | $1.32B 10-Q · filed 2016-11-10 | $3.40B derived: sum of 2 quarters · filed 2017-11-09 | $6.44B 10-Q · filed 2017-11-09 | $6.36B 10-Q · filed 2016-11-10 | $6.27B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-07-03 | $2.05B 10-Q · filed 2017-08-10 | $2.02B 10-Q · filed 2016-08-11 | $5.08B 10-Q · filed 2017-08-10 | $5.04B 10-Q · filed 2016-08-11 | $4.91B derived: sum of 3 quarters · filed 2018-02-22 | $7.04B derived: sum of 4 quarters · filed 2018-02-22 | ||
| 2016-04-03 | $3.04B 10-Q · filed 2017-05-11 | $3.02B 10-Q · filed 2016-05-12 | $2.87B derived: sum of 2 quarters · filed 2018-02-22 | $5.00B derived: sum of 3 quarters · filed 2018-02-22 | $7.62B derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | -$171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $1.96B derived: sum of 2 quarters · filed 2018-02-22 | $4.58B derived: sum of 3 quarters · filed 2018-02-22 | $6.96B 10-K · filed 2018-02-22 | ||||
| 2015-09-27 | $2.13B 10-Q · filed 2016-11-10 | $4.76B derived: sum of 2 quarters · filed 2016-11-10 | $7.13B 10-Q · filed 2016-11-10 | $8.36B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-28 | $2.63B 10-Q · filed 2016-08-11 | $5.00B 10-Q · filed 2016-08-11 | $6.23B derived: sum of 3 quarters · filed 2017-02-23 | $8.89B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-29 | $2.38B 10-Q · filed 2016-05-12 | $3.60B derived: sum of 2 quarters · filed 2017-02-23 | $6.27B derived: sum of 3 quarters · filed 2017-02-23 | $9.18B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $3.89B derived: sum of 2 quarters · filed 2017-02-23 | $6.80B derived: sum of 3 quarters · filed 2017-02-23 | $9.13B 10-K · filed 2017-02-23 | ||||
| 2014-09-28 | $2.67B 10-Q · filed 2015-11-05 | $5.58B derived: sum of 2 quarters · filed 2015-11-05 | $7.91B 10-Q · filed 2015-11-05 | $10.48B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-29 | $2.91B 10-Q · filed 2015-08-06 | $5.24B 10-Q · filed 2015-08-06 | $7.81B derived: sum of 3 quarters · filed 2016-02-29 | $10.40B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-30 | $2.33B 10-Q · filed 2015-05-07 | $4.90B derived: sum of 2 quarters · filed 2016-02-29 | $7.49B derived: sum of 3 quarters · filed 2016-02-29 | $21.59B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $2.57B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $5.16B derived: sum of 2 quarters · filed 2016-02-29 | $19.26B derived: sum of 3 quarters · filed 2016-02-29 | $22.00B 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | $2.59B 10-Q · filed 2014-11-06 | $16.69B derived: sum of 2 quarters · filed 2014-11-06 | $19.43B 10-Q · filed 2014-11-06 | $25.76B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $14.10B 10-Q · filed 2014-08-07 | $16.84B 10-Q · filed 2014-08-07 | $23.16B derived: sum of 3 quarters · filed 2015-02-27 | $26.37B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $2.75B 10-Q · filed 2014-05-08 | $2.74B 10-Q · filed 2013-05-10 | $9.06B derived: sum of 2 quarters · filed 2015-02-27 | $12.27B derived: sum of 3 quarters · filed 2015-02-27 | $15.53B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $6.32B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $9.52B derived: sum of 2 quarters · filed 2015-02-27 | $12.78B derived: sum of 3 quarters · filed 2015-02-27 | $14.57B 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $3.21B 10-Q · filed 2013-11-08 | $6.46B derived: sum of 2 quarters · filed 2013-11-08 | $8.26B 10-Q · filed 2013-11-08 | $9.69B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-07-01 | $3.25B 10-Q · filed 2013-08-09 | $5.05B 10-Q · filed 2013-08-09 | $6.49B derived: sum of 3 quarters · filed 2014-02-28 | $10.22B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-04-01 | $1.79B 10-Q · filed 2013-05-10 | $3.23B derived: sum of 2 quarters · filed 2014-02-28 | $6.97B derived: sum of 3 quarters · filed 2014-02-28 | $9.58B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $5.18B derived: sum of 2 quarters · filed 2014-02-28 | $7.79B derived: sum of 3 quarters · filed 2014-02-28 | $10.01B 10-K · filed 2014-02-28 | ||||
| 2011-10-02 | $3.74B 10-Q · filed 2012-11-09 | $6.35B derived: sum of 2 quarters · filed 2012-11-09 | $8.57B 10-Q · filed 2012-11-09 | $11.46B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-07-03 | $2.61B 10-Q · filed 2011-08-11 | $4.83B 10-Q · filed 2012-08-09 | $7.72B derived: sum of 3 quarters · filed 2013-02-28 | $8.59B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-04-03 | $2.22B 10-Q · filed 2012-05-10 | $5.11B derived: sum of 2 quarters · filed 2013-02-28 | $5.98B derived: sum of 3 quarters · filed 2013-02-28 | $8.45B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $2.89B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.76B derived: sum of 2 quarters · filed 2013-02-28 | $6.23B derived: sum of 3 quarters · filed 2013-02-28 | $8.26B 10-K · filed 2013-02-28 | ||||
| 2010-10-03 | $866.00M 10-Q · filed 2011-11-10 | $3.34B derived: sum of 2 quarters · filed 2011-11-10 | $5.37B 10-Q · filed 2011-11-10 | $6.13B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-07-04 | $2.48B 10-Q · filed 2011-08-11 | $4.50B 10-Q · filed 2011-08-11 | $5.27B derived: sum of 3 quarters · filed 2012-02-28 | $8.15B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-04-04 | $2.03B 10-Q · filed 2011-05-12 | $2.79B derived: sum of 2 quarters · filed 2012-02-28 | $5.67B derived: sum of 3 quarters · filed 2012-02-28 | $7.93B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2009-12-31 | $767.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $3.65B derived: sum of 2 quarters · filed 2012-02-28 | $5.91B derived: sum of 3 quarters · filed 2012-02-28 | $8.63B 10-K · filed 2012-02-28 | ||||
| 2009-09-27 | $2.88B 10-Q · filed 2010-11-12 | $5.14B derived: sum of 2 quarters · filed 2010-11-12 | $7.87B 10-Q · filed 2010-11-12 | |||||
| 2009-06-28 | $2.26B 10-Q · filed 2010-08-12 | $4.99B 10-Q · filed 2010-08-12 | ||||||
| 2008-12-31 | $8.10B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |